Ave Maria Mutual Funds’ Top Healthcare Stocks: SYK, ABT, GILD, MDT, BCR, MTD, JNJ, HLF

Wall St. Watchdog reveals information regarding Ave Maria Mutual Funds’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 14 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $61.454 million.

  • Stryker Corp. (NYSE:SYK): On 06/30/2011, Ave Maria Mutual Funds reported holding 317,400 shares with a market value of $18,628,206. This comprised 2.77% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 320,900 shares with a market value of $15,124,017. This comprised 2.64% of the total portfolio. The net change in shares for this position over the two quarters is 3,500. About Company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Ave Maria Mutual Funds reported holding 253,620 shares with a market value of $13,345,484. This comprised 1.98% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 258,410 shares with a market value of $13,215,087. This comprised 2.3% of the total portfolio. The net change in shares for this position over the two quarters is 4,790. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Varian Medical Systems Inc. (NYSE:VAR): On 06/30/2011, Ave Maria Mutual Funds reported holding 143,700 shares with a market value of $10,061,874. This comprised 1.5% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 138,700 shares with a market value of $7,234,592. This comprised 1.26% of the total portfolio. The net change in shares for this position over the two quarters is -5,000. About Company: Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Ave Maria Mutual Funds reported holding 140,400 shares with a market value of $5,813,964. This comprised 0.86% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 140,400 shares with a market value of $5,447,520. This comprised 0.95% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, Ave Maria Mutual Funds reported holding 147,000 shares with a market value of $5,663,910. This comprised 0.84% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 147,000 shares with a market value of $4,886,280. This comprised 0.85% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Cr Bard Inc. (NYSE:BCR): On 06/30/2011, Ave Maria Mutual Funds reported holding 54,300 shares with a market value of $5,965,398. This comprised 0.89% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 54,300 shares with a market value of $4,753,422. This comprised 0.83% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products.
  • Mettler-toledo International Inc. (NYSE:MTD): On 06/30/2011, Ave Maria Mutual Funds reported holding 31,000 shares with a market value of $5,228,770. This comprised 0.78% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 31,000 shares with a market value of $4,338,760. This comprised 0.76% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Mettler-Toledo International Inc. manufactures and markets weighing instruments for use in laboratory, industrial, and food retailing applications. The Company also supplies several related analytical and measurement technologies. Mettler-Toledo provides its services to customers worldwide.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Ave Maria Mutual Funds reported holding 36,220 shares with a market value of $2,409,354. This comprised 0.36% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 36,010 shares with a market value of $2,293,477. This comprised 0.4% of the total portfolio. The net change in shares for this position over the two quarters is -210. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Herbalife Ltd. (NYSE:HLF): On 06/30/2011, Ave Maria Mutual Funds reported holding 29,000 shares with a market value of $1,671,560. This comprised 0.25% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 37,000 shares with a market value of $1,983,200. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is 8,000. About Company: Herbalife Ltd. is a network marketing company that sells weight management, nutritional supplement and personal care products. The Company sells its products globally through a network of independent distributors. Herbalife also sells literature and promotional materials.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Ave Maria Mutual Funds reported holding 16,100 shares with a market value of $604,233. This comprised 0.09% of the total portfolio. On 09/30/2011, Ave Maria Mutual Funds reported holding 16,100 shares with a market value of $595,217. This comprised 0.1% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.

(Note: Data regarding Ave Maria Mutual Funds’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet